BioCentury
ARTICLE | Clinical News

Arginine deiminase: Phase II

August 4, 2003 7:00 AM UTC

In an Italian Phase II trial in 19 patients, 2 patients had a complete remission and 7 had stable disease. Phoenix said that the average survival was >5 times the historical life expectancy for compar...